Short answer
Labcorp (LH) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). CFO Julia Wang scheduled to speak at UBS Global Healthcare Conference on November 10, 2026.
Labcorp 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- CFO Julia Wang scheduled to speak at UBS Global Healthcare Conference on November 10, 2026
- Investor webcast at 8:45 a.m. ET, with replay available for 180 days
- Potential venue for updated strategic, operating, or financial commentary on Labcorp
Item EX-99.1 · Exhibit EX-99.1
- CFO Julia Wang scheduled to speak November 10 at the UBS Global Healthcare Conference
- Fireside chat webcast may provide updates on strategy, operating trends and capital allocation
- Labcorp serves approximately 100 countries with nearly 71,000 employees
- Company performed more than 750 million patient tests and supported over 85% of FDA-approved drugs in 2025
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Labcorp 8-K filings
Get the next LH 8-K as it lands
Follow LH for push alerts, or ask the research agent what this filing means.